Literature DB >> 22205804

Novel real-time simultaneous amplification and testing method to accurately and rapidly detect Mycobacterium tuberculosis complex.

Zhenling Cui1, Yongzhong Wang, Liang Fang, Ruijuan Zheng, Xiaochen Huang, Xiaoqin Liu, Gang Zhang, Dongmei Rui, Jinliang Ju, Zhongyi Hu.   

Abstract

The aim of this study was to establish and evaluate a simultaneous amplification and testing method for detection of the Mycobacterium tuberculosis complex (SAT-TB assay) in clinical specimens by using isothermal RNA amplification and real-time fluorescence detection. In the SAT-TB assay, a 170-bp M. tuberculosis 16S rRNA fragment is reverse transcribed to DNA by use of Moloney murine leukemia virus (M-MLV) reverse transcriptase, using specific primers incorporating the T7 promoter sequence, and undergoes successive cycles of amplification using T7 RNA polymerase. Using a real-time PCR instrument, hybridization of an internal 6-carboxyfluorescein-4-[4-(dimethylamino)phenylazo] benzoic acid N-succinimidyl ester (FAM-DABCYL)-labeled fluorescent probe can be used to detect RNA amplification. The SAT-TB assay takes less than 1.5 h to perform, and the sensitivity of the assay for detection of M. tuberculosis H37Rv is 100 CFU/ml. The TB probe has no cross-reactivity with nontuberculous mycobacteria or other common respiratory tract pathogens. For 253 pulmonary tuberculosis (PTB) specimens and 134 non-TB specimens, the SAT-TB results correlated with 95.6% (370/387 specimens) of the Bactec MGIT 960 culture assay results. The sensitivity, specificity, and positive and negative predictive values of the SAT-TB test for the diagnosis of PTB were 67.6%, 100%, 100%, and 62.0%, respectively, compared to 61.7%, 100%, 100%, and 58.0% for Bactec MGIT 960 culture. For PTB diagnosis, the sensitivities of the SAT-TB and Bactec MGIT 960 culture methods were 97.6% and 95.9%, respectively, for smear-positive specimens and 39.2% and 30.2%, respectively, for smear-negative specimens. In conclusion, the SAT-TB assay is a novel, simple test with a high specificity which may enhance the detection rate of TB. It is therefore a promising tool for rapid diagnosis of M. tuberculosis infection in clinical microbiology laboratories.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22205804      PMCID: PMC3295177          DOI: 10.1128/JCM.05853-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Conventional methods versus 16S ribosomal DNA sequencing for identification of nontuberculous mycobacteria: cost analysis.

Authors:  Victoria J Cook; Christine Y Turenne; Joyce Wolfe; Ryan Pauls; Amin Kabani
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria.

Authors:  M Cruciani; C Scarparo; M Malena; O Bosco; G Serpelloni; C Mengoli
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Development and clinical trial of fluorescence PCR diagnostic kit to detect Mycobacterium tuberculosis.

Authors:  Gang Cheng; Yun-Shao He; Xin-Yu Zhou; Wen-Guo Deng; Hu Li
Journal:  Di Yi Jun Yi Da Xue Xue Bao       Date:  2002-06

4.  Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens.

Authors:  Claudio Piersimoni; Claudio Scarparo; Paola Piccoli; Alessandra Rigon; Giuliana Ruggiero; Domenico Nista; Stefano Bornigia
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format.

Authors:  D Y Kwoh; G R Davis; K M Whitfield; H L Chappelle; L J DiMichele; T R Gingeras
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

6.  Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens.

Authors:  David W Dowdy; Amelia Maters; Nicole Parrish; Christopher Beyrer; Susan E Dorman
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

7.  Predicting culture results for Mycobacterium tuberculosis complex. Amplified mycobacterium tuberculosis direct test and acid-fast bacilli microscopy.

Authors:  M Gallina; P Troupioti; G Rocco; G Sensalari; E Libanori
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

Review 8.  Use of loop-mediated isothermal amplification of DNA for the rapid detection of Mycobacterium tuberculosis in clinical specimens.

Authors:  I K Neonakis; D A Spandidos; E Petinaki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-18       Impact factor: 3.267

9.  Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa.

Authors:  B Kambashi; G Mbulo; R McNerney; R Tembwe; A Kambashi; V Tihon; P Godfrey-Faussett
Journal:  Int J Tuberc Lung Dis       Date:  2001-04       Impact factor: 2.373

10.  Identification of mycobacteria from culture by using the Gen-Probe Rapid Diagnostic System for Mycobacterium avium complex and Mycobacterium tuberculosis complex.

Authors:  C E Musial; L S Tice; L Stockman; G D Roberts
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

View more
  12 in total

1.  CdTe quantum dots enhance feasibility of EvaGreen-based real-time PCR with decent amplification fidelity.

Authors:  Fuming Sang; Zhizhou Zhang; Zhong Xu; Xiaolei Ju; Hongyuan Wang; Shuanghua Zhang; Changlu Guo
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

Review 2.  Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections.

Authors:  Kuangwen Hsieh; Johan H Melendez; Charlotte A Gaydos; Tza-Huei Wang
Journal:  Lab Chip       Date:  2022-02-01       Impact factor: 7.517

3.  Clinical diagnostic value of simultaneous amplification and testing for the diagnosis of sputum-scarce pulmonary tuberculosis.

Authors:  Liping Yan; Qing Zhang; Heping Xiao
Journal:  BMC Infect Dis       Date:  2017-08-05       Impact factor: 3.090

4.  Rapid diagnosis of pulmonary tuberculosis and detection of drug resistance by combined simultaneous amplification testing and reverse dot blot.

Authors:  Yiwen Chen; Lahong Zhang; Liquan Hong; Xian Luo; Juping Chen; Leiming Tang; Jiahuan Chen; Xia Liu; Zhaojun Chen
Journal:  J Clin Pathol       Date:  2017-11-14       Impact factor: 3.411

5.  Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection.

Authors:  Yayun Liu; Meng Jiang; Jianya Xue; Hongli Yan; Xuesong Liang
Journal:  BMC Gastroenterol       Date:  2019-04-16       Impact factor: 3.067

6.  Accuracy of Commercial Molecular Diagnostics for the Detection of Pulmonary Tuberculosis in China: A Systematic Review.

Authors:  Siwei Deng; Yixin Sun; Hui Xia; Zhike Liu; Le Gao; Jichun Yang; Yanlin Zhao; Fei Huang; Jingnan Feng; Lixia Wang; Shitong Huan; Siyan Zhan
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

7.  Application of real-time simultaneous amplification and testing method to accurately and rapidly detect extra-pulmonary tuberculosis.

Authors:  Tongxin Li; Tao Shi; Ying Sun; Kan Zhou; Zhenggu Huang; Pengsen Wang; Ming Luo; Xiaoping Nie; Guoqiang Yang; Yu Chen; Yaokai Chen
Journal:  BMC Infect Dis       Date:  2020-04-22       Impact factor: 3.090

8.  Comparison of laboratory testing methods for the diagnosis of tuberculous pleurisy in China.

Authors:  Qing Zhang; Caicun Zhou
Journal:  Sci Rep       Date:  2017-07-03       Impact factor: 4.379

9.  A Large Cohort Study on the Clinical Value of Simultaneous Amplification and Testing for the Diagnosis of Pulmonary Tuberculosis.

Authors:  Liping Yan; Shenjie Tang; Yan Yang; Xiang Shi; Yanping Ge; Wenwen Sun; Yidian Liu; Xiaohui Hao; Xuwei Gui; Hongyun Yin; Ya He; Qing Zhang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

10.  Using simultaneous amplification and testing method for evaluating the treatment outcome of pulmonary tuberculosis.

Authors:  Liping Yan; Heping Xiao; Qing Zhang
Journal:  BMC Infect Dis       Date:  2018-10-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.